新冠疫苗接种后前庭神经炎：一项回顾性研究。
Vestibular Neuritis Following COVID-19 Vaccination: A Retrospective Study.
作者信息
Kamogashira Teru, Funayama Hideaki, Asakura Shinnosuke, Ishimoto Shinichi
机构信息
Department of Otolaryngology, JR Tokyo General Hospital, Tokyo, JPN.
Department of Otolaryngology and Head and Neck Surgery, University of Tokyo, Tokyo, JPN.
出版信息
Cureus. 2022 Apr 19;14(4):e24277. doi: 10.7759/cureus.24277. eCollection 2022 Apr.
Objective To determine if the COVID-19 vaccine can cause vestibular neuritis (VN). Design Retrospective study. Setting Vertigo outpatient clinic of the Department of Otolaryngology JR Tokyo General Hospital. Participants: 378 patients who presented at the Vertigo clinic between July 2018 and March 2022 Results 23 out of 378 cases were diagnosed with vestibular neuritis. There was a significant seasonal bias of the onset of VN in 2021-3Q compared to other seasons. All 7 patients diagnosed with VN whose onset was 2021-3Q and 2021-4Q had received the BNT162b2 (Pfizer-BioNTech) vaccine within the previous 3 months and one patient diagnosed with VN whose onset was 2022-1Q had a history of COVID-19 infection six months earlier. Conclusions VN should be recognized as one of the side-effects of the BNT162b2 COVID-19 vaccination.
目的
确定新冠病毒疫苗是否会引发前庭神经炎（VN）。设计：回顾性研究。地点：东京JR综合医院耳鼻喉科眩晕门诊。参与者：2018年7月至2022年3月期间在眩晕门诊就诊的378例患者。结果：378例病例中有23例被诊断为前庭神经炎。与其他季节相比，2021年第三季度VN发病存在明显的季节性偏差。所有7例发病于2021年第三季度和第四季度的VN患者在发病前3个月内接种了BNT162b2（辉瑞-生物科技）疫苗，1例发病于2022年第一季度的VN患者在6个月前有新冠病毒感染史。结论：VN应被视为BNT162b2新冠病毒疫苗接种的副作用之一。
Zotero 插件